Edition:
United Kingdom

Clearside Biomedical Inc (CLSD.OQ)

CLSD.OQ on NASDAQ Stock Exchange Global Market

6.23USD
21 Sep 2018
Change (% chg)

$-0.29 (-4.45%)
Prev Close
$6.52
Open
$6.51
Day's High
$6.57
Day's Low
$6.20
Volume
145,031
Avg. Vol
107,616
52-wk High
$15.27
52-wk Low
$5.32

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.647
Mar '18 0.00 -0.619
FY 2017 Dec '17 0.05 -0.651
Sep '17 0.16 -0.724
Jun '17 0.13 -0.544
Mar '17 0.00 -0.411
FY 2016 Dec '16 0.00 -0.246
Sep '16 0.00 -0.274
Jun '16 0.00 -0.248
Mar '16 0.50 -0.278
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 8 0.00 0.00 0.00 0.00
Quarter Ending Dec-18 8 0.00 0.00 0.00 0.00
Year Ending Dec-18 8 0.00 0.00 0.00 0.00
Year Ending Dec-19 8 4.31 17.45 0.00 10.62
Earnings (per share)
Quarter Ending Sep-18 8 -0.62 -0.50 -0.72 -0.66
Quarter Ending Dec-18 8 -0.64 -0.53 -0.75 -0.73
Year Ending Dec-18 8 -2.52 -2.35 -2.73 -2.13
Year Ending Dec-19 8 -2.25 -1.64 -2.93 -1.97
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.68 32.76
P/E High - Last 5 Yrs. -- 300.70 45.44
P/E Low - Last 5 Yrs. -- 92.08 24.26
Beta -- 0.93 0.89
Price to Sales (TTM) 1,459.03 114.98 5.74
Price to Book (MRQ) 3.89 15.51 5.00
Price to Tangible Book (MRQ) 3.89 14.62 6.57
Price to Cash Flow (TTM) -- 72.88 23.29
% Owned Institutions 68.74 14.70 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.51
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.72 5.22
Payout Ratio(TTM) -- 16.50 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 2,500.00 411.54 8.01
Sales (TTM) vs TTM 1 Yr. Ago -71.57 80.36 5.64
Sales - 5 Yr. Growth Rate -- 32.26 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -119.13 29.14 20.61
EPS (TTM) vs TTM 1 Yr. Ago 29.78 -- --
EPS - 5 Yr. Growth Rate -- 39.84 10.66
Capital Spending - 5 Yr. Growth Rate -- 40.42 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.22
Current Ratio (MRQ) 9.39 5.46 3.03
LT Debt to Equity (MRQ) 11.41 35.27 12.51
Total Debt to Equity (MRQ) 14.35 37.09 16.85
Interest Coverage (TTM) -76.93 -102.34 32.72

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.18 54.37
Gross Margin - 5 Yr. Avg. -- 50.58 52.16
EBITD Margin (TTM) -26,508.28 -- --
EBITD - 5 Yr. Avg -- -600.62 10.68
Operating Margin (TTM) -26,591.04 -759.68 4.33
Operating Margin - 5 Yr. Avg. -- -621.65 6.11
Pre-Tax Margin (TTM) -27,225.52 -733.53 5.18
Pre-Tax Margin - 5 Yr. Avg. -- -627.35 6.51
Net Profit Margin (TTM) -27,225.52 -734.90 1.48
Net Profit Margin - 5 Yr. Avg. -- -630.40 2.78
Effective Tax Rate (TTM) -- 23.33 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.66 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) 6,042 23,229,030 860,305,024
Net Income/Employee (TTM) -1,644,875 3,144,146 101,198,978
Receivable Turnover (TTM) -- 20.89 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) 0.00 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -63.38 -0.15 11.13
Return on Assets - 5 Yr. Avg. -- 3.51 12.40
Return on Investment (TTM) -71.32 1.79 14.61
Return on Investment - 5 Yr. Avg. -- 2.56 16.13
Return on Equity (TTM) -78.78 3.28 16.33
Return on Equity - 5 Yr. Avg. -- 3.43 17.39
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -13.69 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Clearside Biomedical Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 74.21%
# of Holders: 117
Total Shares Held: 23,763,742
3 Mo. Net Change: 373,617
# New Positions: 25
# Closed Positions: 24
# Increased Positions: 72
# Reduced Positions: 47
# Net Buyers: 25
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.